default author photo

Capucine Baldini

Gustave Roussy - Drug Development Department (DITEP)

Villejuif

France

  • Gustave Roussy - Drug Development Department (DITEP)

SCHOLARLY PAPERS

6

DOWNLOADS

304

TOTAL CITATIONS

1

Scholarly Papers (6)

Actions:
Email selected abstracts
1.

Infectious Complications in Patients Treated with T-Cell Engager for Solid Tumours or Haematological Malignancies, a Descriptive Study from the REISAMIC Registry

Number of pages: 33 Posted: 12 Nov 2024
Thomas Hueso, Justin Cagnat, Kaïssa Ouali, Mathilde Haberstitch, Benoit Henry, Alina Danu, Camille Bigenwald, Mansouria Merad, Sabine Messayke, Ariane Laparra, Madona Sakkal, Christina Smolenschi, Antoine Hollebecque, Anas Gazzah, Capucine Baldini, Rastislav Bahleda, Benjamin Besse, Charlotte Rigaud, Véronique Minard, Vincent Ribrag, Salim Laghouati, Elisabeth Chachaty, Fabrice Barlesi, Aurélien Marabelle, Olivier Lambotte, Christophe Massard and Jean-Marie Michot
University of Paris-Saclay - Department of Hematology, Gustave Roussy, Gustave Roussy, Gustave Roussy, University of Paris-Saclay - Institut Pasteur, Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Comité de Pathologies Thoraciques, Université Paris Saclay - Department of Children and Adolescents Oncology, Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Aix Marseille Université, Gustave Roussy, University of Paris-Saclay, Gustave Roussy - Drug Development Department (DITEP) and Gustave Roussy - Drug Development Department (DITEP)
Downloads 114 (621,896)

Abstract:

Loading...

T-cell engager, infections, haematological malignancy, solid tumour

2.

Sequence Analyses of Relapsed or Refractory Diffuse Large B-Cell Lymphomas Unravels Three Genetic Subgroups of Patients and GNA3 Mutant as Poor Prognosis Biomarker, Results of LNH-EP1 Study

Number of pages: 35 Posted: 14 Mar 2022
Jean-Marie Michot, Cyril Quivoron, Clémentine Sarkozy, Alina Danu, Julien Lazarovici, Khalil Saleh, Yolla El-Dakdouki, Vincent Goldschmidt, Camille Bigenwald, Matteo Dragani, Rastislav Bahleda, Capucine Baldini, Julia Arfi-Rouche, Patricia Martin-Romano, Lambros Tselikas, Anas Gazzah, Antoine Hollebecque, Ludovic Lacroix, David Ghez, Veronique Vergé, Christophe Marzac, Sophie Cotteret, Wassila Rahali, Jean-Charles Soria, Christophe Massard, Olivier A. Bernard, Peggy Dartigues, Valérie Camara-Clayette and Vincent Ribrag
Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Translational Research Hematological Laboratory, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Medical Imaging Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Medical Imaging Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Hematology Department, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Hematology Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), INSERM U1170, Université Paris-Saclay, Gustave Roussy, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Translational Research Hematological Laboratory and Gustave Roussy - Drug Development Department (DITEP)
Downloads 63 (933,592)

Abstract:

Loading...

Lymphoma large B-cell diffuse, Molecular sequencing, Prognosis biomarker, Genetic cluster analysis, Guanine nucleotide binding protein (G protein) alpha 13 human

3.

Epigenetic Genes Alterations in Metastatic Solid Tumors: Results from the Prospective Precision Medicine MOSCATO and MATCH-R Trials

Number of pages: 27 Posted: 16 May 2022
Patricia Martin-Romano, Leo Colmet-Daage, Daphne Morel, Capucine Baldini, Loic Verlingue, Anas Gazzah, Rastilav BAHLEDA, Stephane Champiat, Andreea Varga, Jean Marie Michot, Maud Ngo-Camus, Claudio Nicotra, Aurelien Marabelle, Jean-Charles Soria, Etienne Rouleau, Ludovic Lacroix, Antoine Hollebecque, Christophe Massard and Sophie Postel-Vinay
Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Institut d’Hématologie et d’Oncologie Pédiatrique (iHOPe) - Centre Léon Bérard, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP) and Gustave Roussy
Downloads 46 (1,109,210)
Citation 1

Abstract:

Loading...

Epigenetic alterations, Genomics, Precision Medicine, Metastatic solid tumors

4.

Feasibility and clinical relevance of the G-CODE in older adults treated in Phase 1 Clinical Trials at Gustave Roussy

Number of pages: 15 Posted: 15 Oct 2025
Capucine Baldini, Lauren Seknazi, Nikolina Gkolemi, Vincent Goldschmidt, Kaïssa Ouali, Madona Sakkal, Cristina Smolenschi, Antoine Hollebecque, Anas Gazzah, Rastio Bahleda, Thomas Hueso, Jean-Marie Michot, Vincent Ribrag, Sophie Postel Vinay, Aurélien Marabelle, Stephane Champiat, Francois-Xavier Danlos, Zoé ap Thomas, Yohann Loriot, Christophe Massard and Maxime Frelaut
Gustave Roussy - Drug Development Department (DITEP), affiliation not provided to SSRN, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, University of Paris-Saclay - Department of Hematology, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Université Paris XI Sud - Gustave Roussy Cancer Campus, Gustave Roussy - Drug Development Department (DITEP) and Gustave Roussy
Downloads 34 (1,263,436)

Abstract:

Loading...

G-CODE, geriatric assessment, phase 1 clinical trials, older adults, feasibility, Toxicity

5.

Acute kidney injury in patients included in early-phase oncology clinical trials, results of the AKITEP study

Number of pages: 40 Posted: 01 Dec 2025
Matthieu Delaye, Paul Matte, Adrien Mouren, Julien Vibert, Kristi Beshiri, François Lion, Capucine Baldini, Rastislav Bahleda, Anas Gazzah, Kaïssa Ouali, Antoine Hollebecque, Jean-Marie Michot, Cristina Smolenschi, Madona Sakkal, Stevie Yeye, Karine Freon, Mélanie Guibourt, Charline Vincent, Sophie Postel-Vinay, Aurélien Marabelle, Yohann Loriot, Christophe Massard and Matthieu Roulleaux Dugage
Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Université Paris XI Sud - Gustave Roussy Cancer Campus, Gustave Roussy - Drug Development Department (DITEP) and Gustave Roussy
Downloads 25 (1,385,945)

Abstract:

Loading...

acute kidney injury, early-phase clinical trials, oncology, prognosis

6.

Acute Kidney Injury in Patients Included in Early-Phase Oncology Clinical Trials, Results of the Akitep Study

Number of pages: 21 Posted: 07 Jul 2025
Matthieu Delaye, Paul Matte, Adrien Mouren, Julien Vibert, Kristi Beshiri, François Lion, Capucine Baldini, Rastilav BAHLEDA, Anas Gazzah, Kaïssa Ouali, Antoine Hollebecque, Jean-Marie Michot, Cristina Smolenschi, Madona Sakkal, Stevie Yeye, Karine Freon, Mélanie Guibourt, Charline Vincent, Sophie Postel-Vinay, Aurélien Marabelle, Yohann Loriot, Christophe Massard and Matthieu Roulleaux Dugage
Gustave Roussy, Institut Curie, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Université Paris XI Sud - Gustave Roussy Cancer Campus, Gustave Roussy - Drug Development Department (DITEP) and Gustave Roussy
Downloads 22 (1,424,331)

Abstract:

Loading...

acute kidney injury, early-phase clinical trials, Oncology, Prognosis